EFPIA - NEWSLETTER

EFPIA Newsletter 19 October 2023

Europe’s health resilience relies on its ability to innovate

In the face of continued global geopolitical uncertainty, Europe is paying increasing attention to its sovereignty, security and resilience.

The availability of critical medicines and vaccines is central to Europe’s health preparedness. As governments across Europe rebuild and learn from the pandemic, the policies that can build health resilience and strengthen health systems are in sharp focus; the concept of open strategic autonomy is top of the EU policy agenda.

To close the gap, EFPIA proposes to...

The medicine investment gap between US and EU has increased by 1000% over the past 20 years.

The EU Pharmaceutical Legislation will shape the future of research, development and manufacturing in Europe for decades to come. Unless changes are made, Europe will become reliant on other regions' medical innovation and our citizens will wait longer for the latest advances in care.

Have a look at our new webpage on the EU Pharmaceutical Legislation.

News

15 October 2023 EFPIA Japan Day 2023

With a delegation from EFPIA in Brussels, EFPIA Japan recently held “EFPIA Day” in Tokyo

Events

24 OCT 2023

POLITICO Health Care Summit Brussels and online

From pandemic to permacrisis? Europe’s next health care challenge

Learn more →

07 NOV 2023

High-Level Conference on the Value and Role of Incentives in Life Science Brussels, Belgium

Under the auspices of the Ministry of Health of the Czech Republic

Learn more →

14 NOV 2023

Do Novel Oncology Combination Therapies Have a Place Within the EU Legislative Framework?... Bella Center Copenhagen, Denmark

The Impact of Challenges for Novel Combination Therapies on Equality of Access Between European Patients

Learn more →

24 NOV 2023

Awareness session for SMEs on the reform of the EU pharmaceutical legislation Online

Learn more →

What we are reading

Which diabetes specific patient reported outcomes should be measured in routine care? 18 October 2023 (ScienceDirect)

Swedish stakeholders ask for revisions of EU’s pharma reform 17 October 2023 (Euractiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶